{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:38:34Z","timestamp":1793176714626,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Soluble urate leads to a pro-inflammatory phenotype in human monocytes characterized by increased production of IL-1\u03b2 and downregulation of IL-1 receptor antagonist, the mechanism of which remains to be fully elucidated. Previous transcriptomic data identified differential expression of genes in the transforming growth factor (TGF)-\u03b2 pathway in monocytes exposed to urate in vitro. In this study, we explore the role of TGF-\u03b2 in urate-induced hyperinflammation in peripheral blood mononuclear cells (PBMCs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>TGF-\u03b2 mRNA in unstimulated PBMCs and protein levels in plasma were measured in individuals with normouricemia, hyperuricemia and gout. For in vitro validation, PBMCs of healthy volunteers were isolated and treated with a dose ranging concentration of urate for assessment of mRNA and pSMAD2. Urate and TGF-\u03b2 priming experiments were performed with three inhibitors of TGF-\u03b2 signalling: SB-505124, 5Z-7-oxozeaenol and a blocking antibody against TGF-\u03b2 receptor II.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>TGF-\u03b2 mRNA levels were elevated in gout patients compared to healthy controls. TGF-\u03b2-LAP levels in serum were significantly higher in individuals with hyperuricemia compared to controls. In both cases, TGF-\u03b2 correlated positively to serum urate levels. In vitro, urate exposure of PBMCs did not directly induce TGF-\u03b2 but did enhance SMAD2 phosphorylation. The urate-induced pro-inflammatory phenotype of monocytes was partly reversed by blocking TGF-\u03b2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>TGF-\u03b2 is elevated in individuals with hyperuricemia and correlated to serum urate concentrations. In addition, the urate-induced pro-inflammatory phenotype in human monocytes is mediated by TGF-\u03b2 signalling. Future studies are warranted to explore the intracellular pathways involved and to assess the clinical significance of urate-TGF-\u03b2 relation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-023-03001-1","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T03:03:36Z","timestamp":1677467016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["TGF-\u03b2 is elevated in hyperuricemic individuals and mediates urate-induced hyperinflammatory phenotype in human mononuclear cells"],"prefix":"10.1186","volume":"25","author":[{"given":"Viola","family":"Kl\u00fcck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana","family":"Cab\u0103u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Bukkems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"van Emst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"van Caam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"HINT consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioan V.","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu A.","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Rednic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pamfil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Farca\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drago\u015f H.","family":"Marginean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya I.","family":"Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medeea O.","family":"Badii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Hotea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Peca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea-Manuela","family":"Mirea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Nica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doina","family":"Colcear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana S.","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancuta","family":"Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania O.","family":"Cri\u015fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A. B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"issue":"3","key":"3001_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3899\/jrheum.160452","volume":"44","author":"A Shiozawa","year":"2017","unstructured":"Shiozawa A, Szabo SM, Bolzani A, Cheung A, Choi HK. Serum uric acid and the risk of incident and recurrent gout: a systematic review. J Rheumatol. 2017;44(3):388\u201396.","journal-title":"J Rheumatol"},{"issue":"11","key":"3001_CR2","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/art.27667","volume":"62","author":"LA Joosten","year":"2010","unstructured":"Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010;62(11):3237\u201348.","journal-title":"Arthritis Rheum"},{"issue":"suppl_1","key":"3001_CR3","doi-asserted-by":"crossref","first-page":"i12","DOI":"10.1093\/rheumatology\/kex349","volume":"57","author":"A So","year":"2018","unstructured":"So A, Dumusc A, Nasi S. The role of IL-1 in gout: from bench to bedside. Rheumatology (Oxford). 2018;57(suppl_1):i12\u2013i9.","journal-title":"Rheumatology (Oxford)"},{"issue":"10287","key":"3001_CR4","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397(10287):1843\u201355.","journal-title":"Lancet"},{"issue":"11","key":"3001_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649\u201362.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"3001_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jdiacomp.2013.11.012","volume":"28","author":"VG Athyros","year":"2014","unstructured":"Athyros VG, Mikhailidis DP. Uric acid, chronic kidney disease and type 2 diabetes: a cluster of vascular risk factors. J Diabetes Complications. 2014;28(2):122\u20133.","journal-title":"J Diabetes Complications"},{"issue":"2","key":"3001_CR7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","volume":"62","author":"SY Kim","year":"2010","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;62(2):170\u201380.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"3001_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000355405","volume":"3","author":"K Chaudhary","year":"2013","unstructured":"Chaudhary K, Malhotra K, Sowers J, Aroor A. Uric acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 2013;3(3):208\u201320.","journal-title":"Cardiorenal Med"},{"issue":"Pt A","key":"3001_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.arr.2015.01.003","volume":"24","author":"N Feldman","year":"2015","unstructured":"Feldman N, Rotter-Maskowitz A, Okun E. DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res Rev. 2015;24(Pt A):29\u201339.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"3001_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s10067-019-04520-6","volume":"38","author":"IJM Disveld","year":"2019","unstructured":"Disveld IJM, Zoakman S, Jansen T, Rongen GA, Kienhorst LBE, Janssens H, et al. Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and\/or high serum uric acid levels: a prospective cohort study. Clin Rheumatol. 2019;38(5):1385\u201391.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"3001_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","volume":"75","author":"TO Crisan","year":"2016","unstructured":"Crisan TO, Cleophas MC, Oosting M, Lemmers H, Toenhake-Dijkstra H, Netea MG, et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann Rheum Dis. 2016;75(4):755\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3001_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/imr.12833","volume":"294","author":"G Cabau","year":"2020","unstructured":"Cabau G, Crisan TO, Kluck V, Popp RA, Joosten LAB. Urate-induced immune programming: consequences for gouty arthritis and hyperuricemia. Immunol Rev. 2020;294(1):92\u2013105.","journal-title":"Immunol Rev"},{"issue":"2","key":"3001_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","volume":"16","author":"LAB Joosten","year":"2020","unstructured":"Joosten LAB, Crisan TO, Bjornstad P, Johnson RJ. Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol. 2020;16(2):75\u201386.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3001_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13075-021-02580-1","volume":"23","author":"M Badii","year":"2021","unstructured":"Badii M, Gaal OI, Cleophas MC, Kl\u00fcck V, Davar R, Habibi E, et al. Urate-induced epigenetic modifications in myeloid cells. Arthritis Res Ther. 2021;23(1):202.","journal-title":"Arthritis Res Ther"},{"issue":"21","key":"3001_CR15","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1073\/pnas.1620910114","volume":"114","author":"TO Crisan","year":"2017","unstructured":"Crisan TO, Cleophas MCP, Novakovic B, Erler K, van de Veerdonk FL, Stunnenberg HG, et al. Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway. Proc Natl Acad Sci U S A. 2017;114(21):5485\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3001_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng.2500","volume":"45","author":"A Kottgen","year":"2013","unstructured":"Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145\u201354.","journal-title":"Nat Genet"},{"issue":"11","key":"3001_CR17","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol. 2010;11(11):1014\u201322.","journal-title":"Nat Immunol"},{"issue":"4","key":"3001_CR18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/annrheumdis-2019-216233","volume":"79","author":"V Kluck","year":"2020","unstructured":"Kluck V, van Deuren RC, Cavalli G, Shaukat A, Arts P, Cleophas MC, et al. Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout. Ann Rheum Dis. 2020;79(4):536\u201344.","journal-title":"Ann Rheum Dis"},{"issue":"6958","key":"3001_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425(6958):577\u201384.","journal-title":"Nature"},{"issue":"1","key":"3001_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1189\/jlb.0708415","volume":"85","author":"AW Taylor","year":"2009","unstructured":"Taylor AW. Review of the activation of TGF-beta in immunity. J Leukoc Biol. 2009;85(1):29\u201333.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"3001_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","volume":"24","author":"MO Li","year":"2006","unstructured":"Li MO, Wan YY, Sanjabi S, Robertson A-KL, Flavell RA. Transforming growth factor-\u03b2 regulation of immune responses. Annu Rev Immunol. 2006;24(1):99\u2013146.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"3001_CR22","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1074\/jbc.C400503200","volume":"280","author":"Y Naiki","year":"2005","unstructured":"Naiki Y, Michelsen KS, Zhang W, Chen S, Doherty TM, Arditi M. Transforming growth factor-\u03b2 differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling*. J Biol Chem. 2005;280(7):5491\u20135.","journal-title":"J Biol Chem"},{"issue":"1","key":"3001_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/08977199009011007","volume":"4","author":"N McCartney-Francis","year":"1990","unstructured":"McCartney-Francis N, Mizel D, Wong H, Wahl L, Wahl S. TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors. 1990;4(1):27\u201335.","journal-title":"Growth Factors"},{"issue":"16","key":"3001_CR24","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1073\/pnas.84.16.5788","volume":"84","author":"SM Wahl","year":"1987","unstructured":"Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987;84(16):5788\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3001_CR25","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.4049\/jimmunol.142.12.4295","volume":"142","author":"D Chantry","year":"1989","unstructured":"Chantry D, Turner M, Abney E, Feldmann M. Modulation of cytokine production by transforming growth factor-beta. J Immunol. 1989;142(12):4295\u2013300.","journal-title":"J Immunol"},{"issue":"4","key":"3001_CR26","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9(4):e95192.","journal-title":"PLoS One"},{"issue":"1","key":"3001_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12885-015-1177-1","volume":"15","author":"L Humbert","year":"2015","unstructured":"Humbert L, Ghozlan M, Canaff L, Tian J, Lebrun J-J. The leukemia inhibitory factor (LIF) and p21 mediate the TGF\u03b2 tumor suppressive effects in human cutaneous melanoma. BMC Cancer. 2015;15(1):200.","journal-title":"BMC Cancer"},{"issue":"7","key":"3001_CR28","doi-asserted-by":"publisher","first-page":"e1317-e","DOI":"10.1038\/cddis.2014.282","volume":"5","author":"X Shi","year":"2014","unstructured":"Shi X, Guo LW, Seedial SM, Si Y, Wang B, Takayama T, et al. TGF-\u03b2\/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A. Cell Death Dis. 2014;5(7):e1317-e.","journal-title":"Cell Death Dis"},{"issue":"7","key":"3001_CR29","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1002\/art.20317","volume":"50","author":"DR Yagnik","year":"2004","unstructured":"Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO. Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 2004;50(7):2273\u201380.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3001_CR30","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/art.1780390718","volume":"39","author":"F Liote","year":"1996","unstructured":"Liote F, Prudhommeaux F, Schiltz C, Champy R, Herbelin A, Ortiz-Bravo E, et al. Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1. Arthritis Rheum. 1996;39(7):1192\u20138.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3001_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12020-009-9221-z","volume":"36","author":"Y Chen","year":"2009","unstructured":"Chen Y, Huang Y, Li X, Xu M, Bi Y, Zhang Y, et al. Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine. 2009;36(2):262\u20137.","journal-title":"Endocrine"},{"issue":"4","key":"3001_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/annrheumdis-2011-200711","volume":"71","author":"A Scanu","year":"2012","unstructured":"Scanu A, Oliviero F, Ramonda R, Frallonardo P, Dayer JM, Punzi L. Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor beta1 in the resolution phase. Ann Rheum Dis. 2012;71(4):621\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3001_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/s10165-002-0210-9","volume":"13","author":"H Enomoto","year":"2003","unstructured":"Enomoto H, Saito S, Yabe H, Toyama Y, Tomatu T. The levels of leukemia inhibitory factor in synovial tissues of patients with rheumatoid arthritis: inflammation and other proinflammatory cytokines. Mod Rheumatol. 2003;13(2):121\u20138.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"3001_CR34","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1172\/JCI115964","volume":"90","author":"M Lotz","year":"1992","unstructured":"Lotz M, Moats T, Villiger PM. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest. 1992;90(3):888\u201396.","journal-title":"J Clin Invest"},{"key":"3001_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2261-14-18","volume":"14","author":"C Chen","year":"2014","unstructured":"Chen C, Lei W, Chen W, Zhong J, Gao X, Li B, et al. Serum TGF-beta1 and SMAD3 levels are closely associated with coronary artery disease. BMC Cardiovasc Disord. 2014;14:18.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"3001_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40360-020-0386-7","volume":"21","author":"YS Alghamdi","year":"2020","unstructured":"Alghamdi YS, Soliman MM, Nassan MA. Impact of lesinurad and allopurinol on experimental hyperuricemia in mice: biochemical, molecular and immunohistochemical study. BMC Pharmacol Toxicol. 2020;21(1):10.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"3-4","key":"3001_CR37","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1159\/000343567","volume":"121","author":"SM Kim","year":"2012","unstructured":"Kim SM, Choi YW, Seok HY, Jeong KH, Lee SH, Lee TW, et al. Reducing serum uric acid attenuates TGF-beta1-induced profibrogenic progression in type 2 diabetic nephropathy. Nephron Exp Nephrol. 2012;121(3-4):e109\u201321.","journal-title":"Nephron Exp Nephrol"},{"issue":"5","key":"3001_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000105142","volume":"27","author":"KM Talaat","year":"2007","unstructured":"Talaat KM, el-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol. 2007;27(5):435\u201340.","journal-title":"Am J Nephrol"},{"issue":"7","key":"3001_CR39","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"73","author":"JG Coghlan","year":"2014","unstructured":"Coghlan JG, Denton CP, Grunig E, Bonderman D, Distler O, Khanna D, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3001_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/ajh\/hpy157","volume":"32","author":"M Kondo","year":"2019","unstructured":"Kondo M, Imanishi M, Fukushima K, Ikuto R, Murai Y, Horinouchi Y, et al. Xanthine oxidase inhibition by febuxostat in macrophages suppresses angiotensin II-induced aortic fibrosis. Am J Hypertens. 2019;32(3):249\u201356.","journal-title":"Am J Hypertens"},{"issue":"1","key":"3001_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41423-019-0284-3","volume":"18","author":"AK Singh","year":"2021","unstructured":"Singh AK, Haque M, O\u2019Sullivan K, Chourasia M, Ouseph MM, Ahmed S. Suppression of monosodium urate crystal-induced inflammation by inhibiting TGF-beta-activated kinase 1-dependent signaling: role of the ubiquitin proteasome system. Cell Mol Immunol. 2021;18(1):162\u201370.","journal-title":"Cell Mol Immunol."},{"issue":"1","key":"3001_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13075-017-1302-4","volume":"19","author":"A van Caam","year":"2017","unstructured":"van Caam A, Madej W, Garcia de Vinuesa A, Goumans MJ, Ten Dijke P, Blaney Davidson E, et al. TGF\u03b21-induced SMAD2\/3 and SMAD1\/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity. Arthritis Res Ther. 2017;19(1):112.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3001_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009;19(1):128\u201339.","journal-title":"Cell Res"},{"issue":"11","key":"3001_CR44","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1084\/jem.20171491","volume":"215","author":"A Kelly","year":"2018","unstructured":"Kelly A, Gunaltay S, McEntee CP, Shuttleworth EE, Smedley C, Houston SA, et al. Human monocytes and macrophages regulate immune tolerance via integrin \u03b1v\u03b28-mediated TGF\u03b2 activation. J Exp Med. 2018;215(11):2725\u201336.","journal-title":"J Exp Med"},{"issue":"12","key":"3001_CR45","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.joca.2007.04.011","volume":"15","author":"JA Roman-Blas","year":"2007","unstructured":"Roman-Blas JA, Stokes DG, Jimenez SA. Modulation of TGF-\u03b2 signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthr Cartil. 2007;15(12):1367\u201377.","journal-title":"Osteoarthr Cartil"},{"issue":"9","key":"3001_CR46","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/cells8090969","volume":"8","author":"NGM Thielen","year":"2019","unstructured":"Thielen NGM, van der Kraan PM, van Caam APM. TGF\u03b2\/BMP signaling pathway in cartilage homeostasis. Cells. 2019;8(9):969.","journal-title":"Cells."},{"issue":"9","key":"3001_CR47","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.joca.2019.05.013","volume":"27","author":"S Wang","year":"2019","unstructured":"Wang S, Pillinger MH, Krasnokutsky S, Barbour KE. The association between asymptomatic hyperuricemia and knee osteoarthritis: data from the third National Health and Nutrition Examination Survey. Osteoarthr Cartil. 2019;27(9):1301\u20138.","journal-title":"Osteoarthr Cartil"},{"issue":"6","key":"3001_CR48","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/art.40069","volume":"69","author":"S Krasnokutsky","year":"2017","unstructured":"Krasnokutsky S, Oshinsky C, Attur M, Ma S, Zhou H, Zheng F, et al. Serum urate levels predict joint space narrowing in non-gout patients with medial knee osteoarthritis. Arthritis Rheumatol. 2017;69(6):1213\u201320.","journal-title":"Arthritis Rheumatol"},{"key":"3001_CR49","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3389\/fimmu.2018.02452","volume":"9","author":"A van Caam","year":"2018","unstructured":"van Caam A, Vonk M, van den Hoogen F, van Lent P, van der Kraan P. Unraveling SSc pathophysiology; the myofibroblast. Front Immunol. 2018;9:2452.","journal-title":"Front Immunol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03001-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03001-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03001-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T15:28:08Z","timestamp":1701962888000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03001-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3001"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03001-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All ethics approval and consent are described in the methods section of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}